Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles
The present invention relates to an MRI contrast agent that includes zinc-containing water-soluble metal oxide nanoparticles and has an improved contrast effect. The zinc-containing water-soluble metal oxide nanoparticles are characterized by addition of zinc to a matrix comprising the metal oxide n...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
28.06.2016
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention relates to an MRI contrast agent that includes zinc-containing water-soluble metal oxide nanoparticles and has an improved contrast effect. The zinc-containing water-soluble metal oxide nanoparticles are characterized by addition of zinc to a matrix comprising the metal oxide nanoparticles or by substitution of metal in the matrix, resulting in the improved contrast effect of MRI. In addition, the zinc-containing metal oxide nanoparticles of the present invention include the MRI contrast agent t having hybrid structures of "zinc-containing metal oxide nanoparticle-biologically/chemically active material" in which the nanoparticle is conjugated with a bioactive material such as proteins, antibodies, and chemical materials. |
---|---|
Bibliography: | Application Number: US20080527482 |